| AUD | Alcohol Use Disorder |
| BDNF | Brain-Derived Neurotrophic Factor |
| D2/D3 | Dopamine Receptor Subtype 2/Subtype 3 |
| DA | Dopamine |
| FITT | Frequency, Intensity, Time, and Type |
| fNIRS | Functional Near-Infrared Spectroscopy |
| HADS | Hospital Anxiety and Depression Scale |
| HIIT | High-Intensity Interval Training |
| HRmax | Maximum Heart Rate |
| JBI | Joanna Briggs Institute |
| MeSH | Medical Subject Headings |
| min | Minutes |
| PANAS | Positive and Negative Affect Schedule |
| PCC | Population, Concept, and Context |
| PET | Positron Emission Tomography |
| PRISMA-ScR | Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews |
| RCT | Randomized Controlled Trial |
| RPE | Rating of Perceived Exertion |
| STAI-Y1 | State-Trait Anxiety Inventory—Form Y1 |
| SUD | Substance Use Disorder |
| TH | Tyrosine Hydroxylase |
| VO2max | Maximal Oxygen Uptake |